To fold or not to fold: modulation and consequences of Hsp90 inhibition.
about
Approaches for defining the Hsp90-dependent proteome.C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balancesResponse of heat shock protein genes of the oriental fruit moth under diapause and thermal stress reveals multiple patterns dependent on the nature of stress exposureInhibiting heat-shock protein 90 reverses sensory hypoalgesia in diabetic mice.Heat shock protein 90 in Alzheimer's disease3-Arylcoumarin derivatives manifest anti-proliferative activity through Hsp90 inhibition.Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy.Hsp90 C-terminal inhibitors exhibit antimigratory activity by disrupting the Hsp90α/Aha1 complex in PC3-MM2 cells.Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents.Design, synthesis, and biological evaluation of ring-constrained novobiocin analogues as hsp90 C-terminal inhibitorsMolecular chaperone Hsp90 is a therapeutic target for norovirusesHeat shock response and insulin-associated neurodegeneration.Synthesis and evaluation of novologues as C-terminal Hsp90 inhibitors with cytoprotective activity against sensory neuron glucotoxicity.A systematic protocol for the characterization of Hsp90 modulators.Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?Development of Noviomimetics as C-Terminal Hsp90 InhibitorsPromoting Neuronal Tolerance of Diabetic Stress: Modulating Molecular Chaperones.Impaired surface expression and conductance of the KCNQ4 channel lead to sensorineural hearing lossX66, a novel N-terminal heat shock protein 90 inhibitor, exerts antitumor effects without induction of heat shock responseThe SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells.Heat shock protein 70 is necessary to improve mitochondrial bioenergetics and reverse diabetic sensory neuropathy following KU-32 therapy.Alternate strategies of Hsp90 modulation for the treatment of cancer and other diseases.Gα12 structural determinants of Hsp90 interaction are necessary for serum response element-mediated transcriptional activation.Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors.Broad action of Hsp90 as a host chaperone required for viral replication.The role of heat shock protein 90 in modulating ischemia-reperfusion injury in the kidney.Barcoding heat shock proteins to human diseases: looking beyond the heat shock responseSynthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors.Targeting the heat shock protein 90 dimer with dimeric inhibitors.Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.Targeting the Diabetic Chaperome to Improve Peripheral Neuropathy.Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells.Development of a Grp94 inhibitor.Radiosensitizing effect of the novel Hsp90 inhibitor NVP-AUY922 in human tumour cell lines silenced for Hsp90α.Synthesis and biological evaluation of arylated novobiocin analogs as Hsp90 inhibitors.Synthesis and structure-activity relationships of EGCG analogues, a recently identified Hsp90 inhibitorDiverging Novobiocin Anti-Cancer Activity from Neuroprotective Activity through Modification of the Amide Tail.Triazole Containing Novobiocin and Biphenyl Amides as Hsp90 C-Terminal Inhibitors.Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective.Targeting Heat Shock Protein 70 to Ameliorate c-Jun Expression and Improve Demyelinating Neuropathy.
P2860
Q28247643-5E6C1600-A307-4A3D-8825-133C86016F51Q28271643-EDC63615-EAB8-45C3-A953-EB00596D3D82Q31087016-B9FBD5C5-5417-412E-BAC6-CEE843A22A55Q34059530-A6851E8C-AE38-46B2-9A7C-2694CD83130FQ34413279-C49FE429-6274-4EDB-A42D-C6907F2D84A7Q34547161-352F19B2-CC73-4AA9-9F62-1694330E1596Q35116243-E6AEF90D-337B-4AAA-BB1C-099DEE5DCE18Q35121121-98C4A3AE-9EF4-4198-9C84-DC5F2EEBF8A5Q35188962-A3740189-C219-494A-82C6-CD2E1A2CDFB5Q35564420-FD3E26A2-3EA5-48D6-A56A-DF3AF8300E76Q35760516-B16B3664-9397-432F-96B2-E637760FA6BBQ35870561-99FB55AC-1563-4384-B655-C9FFADC065C0Q36077840-B00586F1-E1D0-4D7F-A7B5-7D811B030DBBQ36201554-A1008AC0-A138-4C8E-A354-62C06B02F862Q36293649-B6D87DD3-BAFF-42F0-99FC-EB4ACFCC3282Q36473154-F546AF35-D072-4CDC-857A-CBBCA0D61577Q37057856-357CC7BB-2EDC-4D3F-87E8-709D09B6583CQ37060221-390BAFCC-E32C-43B8-9E22-61EFB19152B3Q37301905-244FD375-E22B-4468-973F-DC55B36CB9A1Q37528354-D6BEC51B-8CFB-487D-A078-67F2DE8A63D8Q37550709-0C562DDA-F676-4029-81CF-385007ACA987Q37622446-F4EEFA29-3CD9-4704-A67E-977C6F77A86EQ37663374-AA5EEAB9-9E01-4799-BC5A-DB996A58FF52Q37813152-91E0DAC7-B9C8-46EA-A84A-088B3CFDF5D5Q37966479-3895919A-38F0-430D-8FB1-0A210690E958Q38033199-1387495C-E310-4F7C-873A-78AD5094BD1EQ38203487-53A37F2D-E2F8-4F69-BD35-12463AF7C5CFQ38428349-91869AEB-77D2-4977-BC7E-15FED99D327FQ38604353-D28E3B21-1CCE-465B-A5E7-3E88728DE173Q38750417-FFFE2372-BE0E-4D91-BA6F-923540E8BDBBQ38869328-BCD91BFA-0882-45F5-B421-A76C52E36D46Q39084975-0149A0E3-3674-4501-97C3-E67E060113CAQ39340802-DB2CD678-309E-47E2-A0AC-10B7292AD49FQ39375187-3203EB2F-E998-4FDC-8142-02770762A25DQ39455379-752A7965-D6AF-4395-8150-86AE6E84F3A8Q41873320-5CC9F753-03C6-4ABC-AEC5-AB77C0BA1276Q42358762-2D28D841-C034-4ECD-A26A-CC9A9F9EE352Q42945545-94034FE9-F024-44A7-9000-6C7EA6D5A628Q47294278-04FD3ABC-D4F1-47D1-86DA-E9F19E9D07BCQ47421684-28608022-0690-446A-8568-C7F63BB619BC
P2860
To fold or not to fold: modulation and consequences of Hsp90 inhibition.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
To fold or not to fold: modulation and consequences of Hsp90 inhibition.
@ast
To fold or not to fold: modulation and consequences of Hsp90 inhibition.
@en
To fold or not to fold: modulation and consequences of Hsp90 inhibition.
@nl
type
label
To fold or not to fold: modulation and consequences of Hsp90 inhibition.
@ast
To fold or not to fold: modulation and consequences of Hsp90 inhibition.
@en
To fold or not to fold: modulation and consequences of Hsp90 inhibition.
@nl
prefLabel
To fold or not to fold: modulation and consequences of Hsp90 inhibition.
@ast
To fold or not to fold: modulation and consequences of Hsp90 inhibition.
@en
To fold or not to fold: modulation and consequences of Hsp90 inhibition.
@nl
P2860
P356
P1476
To fold or not to fold: modulation and consequences of Hsp90 inhibition.
@en
P2093
Brian S J Blagg
Laura B Peterson
P2860
P304
P356
10.4155/FMC.09.17
P577
2009-05-01T00:00:00Z